Home › Peripheral Nerve Disorders › NCT05152368

Safety of Cultured Allogeneic Adult Umbilical Cordor Placental Derived Stem Cells Exosomes for Trigeminal Neuralgia

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells Exosomes for the Treatment of Trigeminal Neuralgia

Who can join

All ages · All sexes

Inclusion Criteria:

* Diagnosis of Trigeminal Neuralgia or Peripheral Neuropathy
* Understanding and willingness to sign a written informed consent document

Exclusion Criteria:

* Active infection
* Active cancer
* Chronic multisystem organ failure
* Pregnancy
* Clinically significant Abnormalities on pre-treatment laboratory evaluation
* Medical condition that would (based on the opinion of the investigator) compromise patient's safety.
* Continued drug abuse
* Pre-menopausal women not using contraception
* Previous organ transplant
* Hypersensitivity to sulfur

About the study

This trial will study the safety and efficacy of instillation of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cell exosomes for the treatment of Trigeminal Neuralgia.

What is being tested

• cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cell exosomes (biological)

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine · Participants: 20 · Started: Sep 9, 2022

Contact the study team

Official record on ClinicalTrials.gov — NCT05152368

Locations in the U.S.

Conditions

• Peripheral Nerve Disorders
• Trigeminal Neuralgia

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.